Health
Amref Health Africa, GE Healthcare Support Africa’s Healthcare Systems
By Dipo Olowookere
GE Healthcare and Amref Health Africa today announced a framework agreement that aims to develop a range of in-country health care service collaborations across reproductive, maternal, newborn and child health, non-communicable diseases, water, sanitation and hygiene and safe surgery.
Initially, Amref Health Africa and GE will work together with Intrahealth and Project HOPE on a new program in Ethiopia, where GE will provide medical equipment at 20 health centres and 4 primary hospitals to widen access to antenatal screenings, essential newborn care and to up skill health workers.
The technology will include portable ultrasound for antenatal screening, baby warmers, anaesthesia and resuscitation equipment used during childbirth and phototherapy devices which help mitigate jaundice in babies.
Through a focus on task-shifting, health workers such as midwives who operate in remote communities where access to medically trained personnel is often limited or non-existent, will be taught essential skills to perform additional tasks such as antenatal scans, ensuring that critical, potentially life-saving services are available to the most at-risk patients.
Amref Health Africa is the largest non-governmental organization founded and based in Africa and has more than 60 years’ experience in health development. GE Healthcare is a leading global provider of healthcare technology and services and brings more than 100 years’ experience in the continent. The collaboration allows the partners to develop new in-country programs that will combine their respective technical expertise, capacity building know-how and ability to convene large-scale funding into programs.
The new GE program with Amref Health Africa will build on results from a 6-month GE pilot during which 22 NICU nurses and paediatricians were trained on the provision of essential newborn care. It showed a 24% reduction in facility-based neo-natal mortality, from 82 in every 1000 admissions to 62 in every 1000 admissions.
The study was conducted by the Ethiopian Paediatric Association in consultation with the Ethiopian Federal Ministry of Health for Ethiopia, at four sites across Ethiopia, and involved more than 2,400 neonates. It also showed a 50% reduction in patient referrals and a 1-day reduction in overall hospital length of stay after an NICU intervention to 7 days.
“Amref Health Africa stands at the forefront of creating stronger community-based health systems that ensure access to quality health services for all. Training health workers on essential skills for mother and child health is a key component of addressing the high rates of maternal, newborn and child mortality that still exists in far too many communities,” said Dr. Githinji Gitahi Group CEO, Amref Health Africa.
“Strengthening primary care and the broader referral system is an essential building block towards the attainment of universal health coverage in Africa,” said Farid Fezoua, President and CEO, GE Healthcare Africa. “To that end, Amref Health Africa – as a proven and trusted partner in African healthcare, has been at the forefront of primary care development. Leveraging their unique insights and local know-how is an important step in GE’s plan to contribute meaningfully to the reduction of preventable maternal and child mortality.”
He added: “Our approach combines relevant technologies, skills development and localized service delivery into one scalable deployment model. Early pilots have shown promising results and together with Amref Health Africa and our other implementation partners, we have a dedicated and local team monitoring and evaluating these programs to share learnings across the continent.”
Today there are more than a dozen GE Healthcare programs in Nigeria, Tanzania, Kenya, Ghana, South Africa and Sierra Leone aimed at reducing preventable maternal and infant mortality underway together with a range of implementation partners. With a plan to deliver more than 20 such initiatives with several partners including Amref Health Africa, GE aims to reach 3.5 million expectant women, mothers and new-borns and train over 3,000 primary healthcare workers by 2020.
According to WHO, approximately 830 women die every day from preventable causes related to pregnancy and childbirth, with maternal mortality higher in women living in rural areas and among poorer communities.
Almost all maternal deaths (99%) occur in developing countries. More than half of these deaths occur in sub-Saharan Africa. The situation remains challenging for infants and newborns. While the total number of under-five deaths dropped to 5.6 million in 2016 from 12.6 million in 1990, 7,000 newborns still die every day, according to UNICEF.
In sub-Saharan Africa, approximately 1 child in 13 dies before his or her fifth birthday, while in the world’s high-income countries the ratio is 1 in 189.
One target under Sustainable Development Goal 3 is to reduce the global maternal mortality ratio to less than 70 per 100 000 births, with no country having a maternal mortality rate of more than twice the global average. To that end, skilled care before, during and after childbirth can save the lives of women and newborn babies according to WHO.
Amref Health Africa has a strong regional presence, working with over 100 poor and marginalized rural and urban slum communities as well as district health authorities and Ministries of Health and Education in Ethiopia, Kenya, South Africa, South Sudan, Tanzania and Uganda; pioneering experience in community based healthcare – emphasizing community ownership of projects and programs to encourage sustainability; and extensive experience in health development training targeted at a diverse range of health professionals from primary healthcare workers to field surgeons.
By Adedapo Adesanya
The National Health Insurance Authority (NHIA) says the number of Nigerians enrolled in health insurance has risen to more than 22 million.
The Director-General of NHIA, Mr Kelechi Ohiri, said this resulted from the implementation of the mandatory health insurance, which has gained momentum nationwide.
He said this on Wednesday at the Annual General Meeting of the Nigerian Association of Insurance and Pension Editors (NAIPE) in Lagos.
Mr Ohiri said enrolment had increased to 22.03 million, representing a 35 per cent year-on-year growth, attributing this to stronger collaboration with state social health insurance agencies, ministries, departments and agencies, organised labour, employers, the private sector, and the gradual implementation of the mandatory health insurance provisions of the NHIA Act.
He said that the country had moved beyond policy formulation to delivering measurable improvements in healthcare access, service quality and consumer protection in line with the federal government’s health sector reform agenda.
According to him, Nigeria already has the necessary policies and legislation to achieve Universal Health Coverage, positing that the key challenge was effective implementation.
“The decisive variable is now implementation- consistent, rigorous and accountable execution that converts political commitment into healthcare access for real Nigerians,” he said.
Mr Ohiri said that the transition from the former National Health Insurance Scheme to the NHIA had strengthened regulation, consumer protection, accountability and strategic purchasing, while providing the legal and operational framework for achieving Universal Health Coverage.
He added that improving the experience of enrollees remained central to the Authority’s reform agenda.
According to him, NHIA has strengthened its complaints management system, introduced faster resolution timelines, and intensified compliance monitoring of Health Maintenance Organisations (HMOs) and healthcare providers.
He further added that NHIA had sanctioned facilities that failed to meet the required standards, adding that his organisation had resolved 3,878 complaints, representing an 87 per cent resolution rate, while 95 per cent of the cases were concluded within prescribed timelines.
Mr Ohiri noted that more than N14.2 million had been refunded to enrollees, while non-compliant healthcare facilities had been sanctioned.
He said NHIA had also introduced service standards, including a one-hour treatment commencement target for enrollees requiring urgent care, to improve access to timely and quality healthcare services.
The NHIA boss further disclosed that capitation payments to healthcare providers had been increased by 93 per cent.
He said fee-for-service reimbursements rose by 378 per cent to enable providers to invest more in personnel, equipment and infrastructure.
According to him, 7,592 healthcare facilities have been assessed under the SafeCare quality framework as part of efforts to institutionalise continuous quality improvement across the country.
Mr Ohiri also highlighted interventions targeted at vulnerable groups, including support for more than 48,500 pregnant women, expanded maternal and newborn healthcare services, the Vulnerable Group Fund, and improved access to healthcare for pensioners and retirees.
He said Universal Health Coverage could only be achieved if every Nigerian, regardless of income or location, had access to quality healthcare services.
By Modupe Gbadeyanka
The new one-hour authorisation response time ultimatum policy introduced by the National Health Insurance Authority (NHIA) has received the full backing of SUNU Health Nigeria Limited.
This policy was introduced by the agency to ensure enrollees get prompt approval codes to access care.
Healthcare service providers have been urged to report any Health Maintenance Organisation (HMO) that violates this initiative through an email, with the HMO in copy and a timestamp attached as evidence of the request. They may proceed to offer services to enrollees thereafter.
Speaking at the company’s second-quarter Providers’ Forum for the Lagos-Ogun region in Lagos recently, the chief executive of SUNU Health, Dr Moyosore Olomola, expressed optimism that this policy would improve healthcare delivery in the country, especially for enrollees, who crave quality service.
At the event themed Improving Quality and Access to Care Through Stronger Provider Network, and held at the Nigerian Institute of Medical Research (NIMR) in Yaba, Lagos, Mr Olomola reaffirmed the HMO’s commitment to operating within legal and operational frameworks to guarantee adequate care for enrollees.
“Access to care and quality of care remain key priorities in our healthcare systems. We know quite well that deliberate collaboration, strategic partnerships, and a shared commitment to excellence are required to achieve these priorities.
“A strong provider network is doubtless the backbone of any effective healthcare system. It ensures that our mutual enrollees receive the right care, at the right time, in the right place, and at the right price,” Mr Olomola, represented at the programme by the organisation’s Chief Operating Officer (COO), Dr Faith Nwachi, stated.
He further assured that SUNU Health would strictly adhere to the one-hour authorisation limit, stressing that this aligns seamlessly with one of the organisation’s core values—promptness and its corporate slogan, Humanity is the centre of our initiatives.
In a bid to further improve access and quality of care, SUNU Health also demonstrated its new operational software and Mobile app, aptly named SUNU Legacy.
Also speaking at the event, the NHIA Lagos State Coordinator (Ikeja), Dr Bethuel-Kasimu Abraham, noted that the forum’s expected outcome is to significantly reduce delays in accessing medical care.
Other key expectations include ensuring continuity of care, improving patient outcomes, and strengthening accountability among HMOs.
Addressing specific pain points faced by enrollees, the NHIA Ogun State Coordinator, Mr Dare Adefeso, acknowledged that the agency had received complaints regarding out-of-stock drugs and the discrimination of enrollees by certain providers.
He affirmed that the NHIA is actively addressing these issues, stressing that moving forward, every facility must ensure enrollees are properly catered to regardless of their status, provided they have an active health insurance plan.
Corroborating the long-standing legacy of SUNU Health, the Ogun State Director of the National Orientation Agency (NOA), Mrs Aishat Tiamiyu, shared that her agency is responsible for public information dissemination and has been enrolled with SUNU Health for over 25 years.
Commending the HMO’s stellar service over two decades, she called for the immediate enrollment of new NOA staff into the scheme.
The Providers’ Forum remains one of the strategic channels employed by SUNU Health to consistently engage healthcare providers, understand their operational challenges, introduce new software updates, and solidify partnerships aimed at fostering premium healthcare delivery across Nigeria.
By Aduragbemi Omiyale
The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a sexual enhancement product known as WAP Sensual Enhancement Capsules.
In a statement on Monday, the Nigerian agency disclosed that the recall is due to “undeclared pharmaceutical ingredients” in the product, whose country of origin is unknown, but is marketed and distributed online in the US through eBay.
It was emphasised that the recall is being “voluntarily” made by the manufacturer, Best Supplements Best Prices Company.
The detection of the undeclared pharmaceutical ingredients was made by the US Food and Drug Administration (FDA).
Laboratory analysis by the US FDA revealed that the product contained undeclared sildenafil, tadalafil, and flibanserin, which were not mentioned on the product label. Such substances may include phosphodiesterase type-5 (PDE-5) inhibitors or related compounds commonly used for the treatment of erectile dysfunction, the statement by NAFDAC stated.
Sildenafil and tadalafil are ingredients in FDA-approved prescription drugs used to treat erectile dysfunction.
It was noted that these undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Flibanserin is the active ingredient in an FDA-approved prescription drug used to treat low sexual desire in women. Flibanserin can cause drowsiness, sedation, dangerously low blood pressure, and fainting, especially when combined with alcohol.
Consumers have been encouraged to report compromised products (medicines or medical devices) to the nearest NAFDAC office, call 0800-162-3322, or send an email to sf******@********ov.ng.
